Bupivacaine

Chemical structure and pharmacodynamic properties

In terms of its chemical structure, bupivacaine is classified as a member of the substituted amide group. In its basic structure, the drug has a certain similarity to lidocaine, but significantly surpasses it in potency and duration of effect. In clinical practice, this medicinal product is traditionally used in the form of hydrochloride.

The pharmacodynamics of the drug are characterized primarily by its belonging to the most active local anesthetics available in modern medicine. The main distinctive feature is the ability to induce exceptionally powerful and, importantly, prolonged anesthesia. The effect after administration can persist for anywhere from 3 to 10 hours, and in certain clinical situations this period turns out to be even longer. It is precisely this property that determines the specific choice of this amide anesthetic for prolonged procedures.

Dosing regimens and solution concentrations

Since the drug is characterized by high potency, strictly calibrated concentrations are required to achieve adequate analgesia, which vary depending on the chosen regional anesthesia technique. Using the correct percentage ratio is critically important to ensure a balance between block efficacy and patient safety.

Recommended solution concentrations for various types of anesthesia:

• Infiltration anesthesia: a solution with the lowest concentration — 0.25% — is used.
• Nerve block (blockade of nerve trunks and plexuses): a range from 0.25% to 0.5% is used.
• Spinal (subarachnoid) anesthesia: similar to nerve blocks, 0.25–0.5% solutions are used.
• Epidural anesthesia: requires the use of a more concentrated solution — 0.75%.
• Retrobulbar block: also involves the use of a 0.75% solution.

Special attention should be paid to the use of the drug in obstetrics and gynecology. A strict restriction is established in this field: the use of solutions with a concentration strictly within 0.25–0.5% is permissible. The use of higher concentrations (e.g., 0.75%) in obstetric practice is categorically not recommended due to a sharp increase in the risk of toxic complications.

Toxicological profile and risks of intoxication

The high pharmacological potency of long-acting amide anesthetics, to which bupivacaine belongs, is inextricably linked with an increased risk of developing systemic toxicity. Complications can occur with accidental intravascular administration or when exceeding permissible concentrations.

The clinical picture of intoxication is characterized by severe damage to two main body systems:

1. Central nervous system: overdose manifests with a pronounced neurotoxic effect, the main sign of which is the risk of seizures.
2. Cardiovascular system: the drug has high cardiotoxicity. Intoxication leads to profound depression of cardiac activity. In an unfavorable scenario, this depression can rapidly progress up to complete cardiac arrest.

It is precisely because of these fatal risks (seizures, bradycardia, decreased contractility, and cardiac arrest) that careful dosage control is required, especially in vulnerable categories of patients such as pregnant women.

Class and exam questions

What else to study on this topic

• Comparative characteristics of amide and ester local anesthetics
• Mechanisms of cardiotoxicity of long-acting amides
• Features of performing a retrobulbar block
• Prevention and management of local anesthetic systemic toxicity (LAST)
• Specifics of pharmacodynamics in spinal anesthesia

Other topics in the "Analgesics" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.